NTP-A
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
NeuroTherapeutics Pharma, EF
Mechanism of Action
Other
Mechanism Description
Symporter inhibitor
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link